BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37310241)

  • 61. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Strategies for expanding colorectal cancer screening at community health centers.
    Sarfaty M; Doroshenk M; Hotz J; Brooks D; Hayashi S; Davis TC; Joseph D; Stevens D; Weaver DL; Potter MB; Wender R
    CA Cancer J Clin; 2013; 63(4):221-31. PubMed ID: 23818334
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
    Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
    Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Colonoscopy Versus Fecal Immunochemical Test for Reducing Colorectal Cancer Risk: A Population-Based Case-Control Study.
    Kim SY; Kim HS; Kim YT; Lee JK; Park HJ; Kim HM; Kang DR
    Clin Transl Gastroenterol; 2021 Apr; 12(5):e00350. PubMed ID: 33928919
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial.
    Green BB; Wang CY; Anderson ML; Chubak J; Meenan RT; Vernon SW; Fuller S
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):301-11. PubMed ID: 23460053
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region.
    Chiu HM; Su CW; Hsu WF; Jen GH; Hsu CY; Chen SL; Chen HH
    Prev Med; 2021 Oct; 151():106622. PubMed ID: 34044024
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
    Peterse EFP; Meester RGS; Siegel RL; Chen JC; Dwyer A; Ahnen DJ; Smith RA; Zauber AG; Lansdorp-Vogelaar I
    Cancer; 2018 Jul; 124(14):2964-2973. PubMed ID: 29846933
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Modifications in Primary Care Clinics to Continue Colorectal Cancer Screening Promotion During the COVID-19 Pandemic.
    Arena L; Soloe C; Schlueter D; Ferriola-Bruckenstein K; DeGroff A; Tangka F; Hoover S; Melillo S; Subramanian S
    J Community Health; 2023 Feb; 48(1):113-126. PubMed ID: 36308666
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center.
    Baker DW; Brown T; Buchanan DR; Weil J; Cameron KA; Ranalli L; Ferreira MR; Stephens Q; Balsley K; Goldman SN; Wolf MS
    BMC Health Serv Res; 2013 Apr; 13():153. PubMed ID: 23627550
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System.
    Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA
    J Gen Intern Med; 2016 Nov; 31(11):1323-1330. PubMed ID: 27412426
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Colonoscopy quality assessment in a mass population screening programme based on faecal occult blood test.
    Binefa G; García M; Milà N; Rodríguez L; Rodríguez-Moranta F; Guardiola J; Moreno V
    Rev Esp Enferm Dig; 2013 Aug; 105(7):400-8. PubMed ID: 24206550
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Improving colorectal cancer screening in rural primary care: Preliminary effectiveness and implementation of a collaborative mailed fecal immunochemical test pilot.
    Davis MM; Coury J; Larson JH; Gunn R; Towey EG; Ketelhut A; Patzel M; Ramsey K; Coronado GD
    J Rural Health; 2023 Jan; 39(1):279-290. PubMed ID: 35703582
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Improving the follow-up of positive hemoccult screening tests: an electronic intervention.
    Humphrey LL; Shannon J; Partin MR; O'Malley J; Chen Z; Helfand M
    J Gen Intern Med; 2011 Jul; 26(7):691-7. PubMed ID: 21327529
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Improving Fecal Immunochemical Test Return Rates: A Colorectal Cancer Screening Quality Improvement Project in a Multisite Federally Qualified Health Center.
    Zoellner JM; Porter KJ; Thatcher E; Allanson D; Brauns M
    Health Promot Pract; 2023 Jul; 24(4):740-754. PubMed ID: 35382617
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve three-year adherence to colorectal cancer screening among patients cared for in rural community health centers.
    Davis TC; Morris JD; Reed EH; Curtis LM; Wolf MS; Davis AB; Arnold CL
    Contemp Clin Trials; 2022 Feb; 113():106654. PubMed ID: 34906745
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Perdue LA; Henrikson NB; Bean SI; Blasi PR
    JAMA; 2021 May; 325(19):1978-1998. PubMed ID: 34003220
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rates of Follow-up Colonoscopy After a Positive Stool-Based Screening Test Result for Colorectal Cancer Among Health Care Organizations in the US, 2017-2020.
    Mohl JT; Ciemins EL; Miller-Wilson LA; Gillen A; Luo R; Colangelo F
    JAMA Netw Open; 2023 Jan; 6(1):e2251384. PubMed ID: 36652246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.